SPOTLIGHT -
USP safety review column
First Oral Antiviral Treatment For COVID-19 Gets FDA Approval
More than 11.6 million treatment courses of the medication have been prescribed in the U.S. to date.
RPhCast, Episode One: Statins, Blood Pressure, and Curves Galore
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
A National Drug Shortage Creates Care Challenges in Oncology
A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.
How Independent Pharmacists Build Their Brand In A Crowded Market
Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.
What Is The Link Between Antidepressants and Hospital-Acquired Clostridium Difficile Infection?
Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.
Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval
The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
